🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 18 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 03/02/2014 | 38,56 | 38,67 | 35,69 | 36,79 | -4,79% | 7,73% | 530.433 |
| 31/01/2014 | 38,15 | 38,98 | 37,62 | 38,64 | -1,56% | 3,58% | 224.099 |
| 30/01/2014 | 38,94 | 39,84 | 38,82 | 39,25 | +2,01% | 2,61% | 256.640 |
| 29/01/2014 | 38,01 | 39,42 | 37,75 | 38,48 | +0,39% | 4,38% | 277.800 |
| 28/01/2014 | 36,92 | 38,68 | 36,68 | 38,33 | +4,56% | 5,42% | 414.696 |
| 27/01/2014 | 37,92 | 37,92 | 35,46 | 36,66 | -2,49% | 6,50% | 675.023 |
| 24/01/2014 | 40,62 | 40,62 | 36,95 | 37,59 | -8,39% | 9,04% | 730.968 |
| 23/01/2014 | 40,70 | 41,06 | 39,74 | 41,04 | +0,47% | 3,23% | 395.941 |
| 22/01/2014 | 40,86 | 40,86 | 39,58 | 40,84 | +0,00% | 3,13% | 266.900 |
| 21/01/2014 | 40,24 | 40,96 | 38,71 | 40,84 | +1,88% | 5,60% | 473.366 |
| 17/01/2014 | 40,13 | 40,95 | 39,71 | 40,09 | +0,08% | 3,08% | 433.131 |
| 16/01/2014 | 39,39 | 40,21 | 38,91 | 40,06 | +1,95% | 3,29% | 332.943 |
| 15/01/2014 | 38,60 | 39,48 | 38,60 | 39,29 | +1,89% | 2,29% | 477.213 |
| 14/01/2014 | 37,16 | 38,70 | 37,16 | 38,56 | +4,09% | 4,16% | 352.981 |
| 13/01/2014 | 36,99 | 38,63 | 36,59 | 37,04 | +0,12% | 5,50% | 533.639 |
| 10/01/2014 | 36,19 | 37,11 | 35,30 | 37,00 | +2,38% | 5,00% | 359.713 |
| 09/01/2014 | 34,82 | 36,17 | 34,61 | 36,14 | +4,47% | 4,48% | 416.620 |
| 08/01/2014 | 33,18 | 34,62 | 32,71 | 34,59 | +4,09% | 5,77% | 557.203 |
| 07/01/2014 | 32,30 | 33,59 | 32,13 | 33,23 | +3,36% | 4,54% | 395.300 |
| 06/01/2014 | 32,35 | 32,84 | 31,65 | 32,15 | -0,92% | 3,70% | 388.567 |
| 03/01/2014 | 32,25 | 32,89 | 32,25 | 32,45 | +0,97% | 1,97% | 321.882 |
| 02/01/2014 | 32,72 | 33,06 | 31,83 | 32,14 | -2,05% | 3,76% | 487.312 |
| 31/12/2013 | 33,48 | 33,48 | 32,38 | 32,81 | -2,07% | 3,30% | 530.112 |
| 30/12/2013 | 33,83 | 34,01 | 33,23 | 33,51 | -0,70% | 2,31% | 274.594 |
| 27/12/2013 | 33,93 | 34,29 | 33,42 | 33,74 | -0,70% | 2,56% | 188.673 |
| 26/12/2013 | 34,29 | 34,62 | 33,84 | 33,98 | -0,86% | 2,29% | 197.650 |
| 24/12/2013 | 34,61 | 34,92 | 33,97 | 34,27 | -1,72% | 2,74% | 156.934 |
| 23/12/2013 | 34,63 | 34,88 | 33,94 | 34,87 | +1,16% | 2,70% | 524.662 |
| 20/12/2013 | 33,51 | 34,75 | 33,39 | 34,47 | +3,48% | 4,08% | 1.155.442 |
| 19/12/2013 | 32,38 | 33,33 | 31,98 | 33,31 | +2,44% | 4,18% | 528.830 |